DEXCOM, INC. Debt Securities, Available-for-sale
DEXCOM, INC. (DXCM) had Debt Securities, Available-for-sale of $1.80 billion as of 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-05-01
- 2025-03-31: Debt Securities, Available-for-sale $1.80B.
- 2024-12-31: Debt Securities, Available-for-sale $1.97B.
- 2024-09-30: Debt Securities, Available-for-sale $1.87B.
- 2024-06-30: Debt Securities, Available-for-sale $2.18B.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2025-03-31 | $1.80B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $1.97B 10-Q · filed 2025-05-01 | |
| 2024-09-30 | $1.87B 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $2.18B 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $2.05B 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $2.16B 10-K · filed 2025-02-18 | |
| 2023-09-30 | $2.60B 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $2.44B 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $1.94B 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $1.81B 10-K · filed 2024-02-08 | |
| 2022-09-30 | $1.67B 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $2.02B 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $1.97B 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $1.68B 10-K · filed 2023-02-09 | |
| 2021-09-30 | $1.25B 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $1.43B 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $1.90B 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $1.89B 10-K · filed 2022-02-14 | |
| 2020-09-30 | $1.93B 10-Q · filed 2020-10-27 | |
| 2020-06-30 | $1.98B 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $925.90M 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $1.09B 10-K · filed 2021-02-11 | |
| 2019-09-30 | $1.03B 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $668.30M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $72.90M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $210.60M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $258.50M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $250.80M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $210.60M 10-Q · filed 2019-05-01 | $101.10M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $107.10M 10-K · filed 2019-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |